misonneh's comments [65 articles] Export

Recent papers added to misonneh's library classified by the tag comments. You can also see everyone's comments.

	SnapShot: the human DNA methylome in health and disease. [My Copy] Cell, Vol. 135, No. 6. (12 December 2008), pp. 1144-1144.e1. by Esteban Ballestar, Manel Esteller posted to review methylation mapping comments by misonneh on 2009-11-24 07:22:15 as along with 1 person guhjy
	Breast Cancer Racial Gap Examined: No Easy Answers to Explain Disparities in Survival [My Copy] JAMA, Vol. 290, No. 14. (8 October 2003), pp. 1838-1842. by Brian Vastag posted to race disparities comments breast by misonneh on 2009-11-24 07:02:38 as
	Epigenetics: An expanding horizon for DNA methylation [My Copy] Nat Rev Genet, Vol. 10, No. 12. (27 October 2009), pp. 818-819. by Mary Muers posted to review methylation epigenetics comments by misonneh on 2009-11-19 06:04:35 as along with 1 person megraw
	Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision? [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 170-177. by L. J. Lesko posted to pharmacogenetics perspective design comments by misonneh on 2009-11-19 05:41:44 as along with 1 person rwinegar
	Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 153-155. by C. Wilson, S. Schulz, S. A. Waldman posted to translation design comments biomarker by misonneh on 2009-11-19 05:36:19 as along with 1 person guhjy
	Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (23 October 2009), pp. 842-843. by Ke-Da Yu, Zhi-Ming Shao posted to tamoxifen review pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-11-19 05:26:25 as
	Genomics: We are individuals [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (01 November 2009), pp. 770-771. by Gemma K. Alderton posted to technology subtypes pharmacogenetics metastasis genetics dynamic comments breast biomarker by misonneh on 2009-11-19 02:18:41 as
	Current Understanding of the Pharmacogenomics of Metformin [My Copy] Clinical Pharmacology & Therapeutics, Vol. 86, No. 6. (01 December 2009), pp. 595-598. by O. Zolk posted to transport review pharmacogenetics metformin comments by misonneh on 2009-11-18 02:40:31 as
	5-methylcytosine--the fifth base of DNA: the fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer? [My Copy] Disease markers, Vol. 23, No. 1-2. (2007), pp. 1-3. by Martin Widschwendter posted to risk_assessment methylation epigenetics comments chemotherapy biomarker 5mdc by misonneh on 2009-11-04 21:48:18 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Epigenetic Therapies Move Into New Territory, but How Exactly Do They Work? [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 19. (7 October 2009), pp. 1300-1301. by Rabiya S. Tuma posted to epigenetics drug_discovery comments chemotherapy by misonneh on 2009-10-07 02:14:53 as
	Personalized medicine: elusive dream or imminent reality? [My Copy] Clinical pharmacology and therapeutics, Vol. 81, No. 6. (June 2007), pp. 807-816. by L. J. Lesko posted to review pharmacogenetics fda comments by misonneh on 2009-09-29 18:29:20 as along with 2 people junbo_yin PredictER
	SLCO1B1 variants and statin-induced myopathy. [My Copy] The New England journal of medicine, Vol. 360, No. 3. (15 January 2009) by Georgirene D. Vladutiu, Paul J. Isackson posted to statin slco1b1 comments adr by misonneh on 2009-09-29 18:19:21 as
	Pharmacogenomics and drug toxicity. [My Copy] The New England journal of medicine, Vol. 359, No. 8. (21 August 2008), pp. 856-858. by Yusuke Nakamura posted to pharmacogenetics comments adr by misonneh on 2009-09-29 18:18:37 as along with 1 person Amazoness
	Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. [My Copy] The New England journal of medicine, Vol. 358, No. 6. (7 February 2008), pp. 637-639. by Magnus Ingelman-Sundberg posted to pharmacogenetics comments adr by misonneh on 2009-09-29 17:46:44 as
	MicroRNA reexpression as differentiation therapy in cancer. [My Copy] The Journal of clinical investigation, Vol. 119, No. 8. (August 2009), pp. 2119-2123. by Prasun J. Mishra, Glenn Merlino posted to mirna expression comments chemoprevention by misonneh on 2009-09-29 17:18:53 as along with 1 person guhjy
	Genome-Wide Association Studies Provoke Debate and a New Look at Strategy [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 15. (5 August 2009), pp. 1041-1043. by Rabiya S. Tuma posted to comments perspective gwas by misonneh on 2009-08-05 07:02:59 as along with 2 people and 1 group Zephyrus pkonings MGEL Reading
	Genotype-guided tamoxifen therapy: time to pause for reflection? [My Copy] The Lancet Oncology, Vol. 10, No. 8. (August 2009), pp. 825-833. by Timothy L. Lash, Ernst A. Lien, Henrik T. Sørensen, Stephen Hamilton-Dutoit posted to tamoxifen review pharmacogenetics perspective genetics comments by misonneh on 2009-07-30 01:47:41 as
	Oncology Information Exchange opens up databases [My Copy] The Lancet Oncology, Vol. 10 (August 2009), 755. by Richard Begent posted to cancer comments database by misonneh on 2009-07-30 01:33:31 as
	Invited Commentary: Assessing Treatment Effects by Using Observational Analyses--Opportunities and Limitations [My Copy] Am. J. Epidemiol., Vol. 170, No. 3. (1 August 2009), pp. 286-287. by Philip S. Wang, Michael Schoenbaum posted to bias comments observation statistics by misonneh on 2009-07-27 09:37:10 as
	A Holy Grail of Clinical Pharmacology: Prediction of Drug Pharmacokinetics and Pharmacodynamics in the Individual Patient [My Copy] Clin Pharmacol Ther, Vol. 86, No. 2. (21 July 2009), pp. 133-134. by L. Z. Benet posted to comments cyp3a4 pharmacogenetics pk prediction by misonneh on 2009-07-22 03:33:40 as
	Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications [My Copy] Nature Reviews Genetics, Vol. 10, No. 8. (01 August 2009), pp. 578-585. by Brian D. Brown, Luigi Naldini posted to comments mirna moa review therapy by misonneh on 2009-07-20 10:10:20 as along with 5 people and 2 groups heliopais guhjy ppgardne reyez valeriehilgers microRNA Journal picks
	Breast Cancer Single-Nucleotide Polymorphisms: Statistical Significance and Clinical Utility [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 14. (15 July 2009), pp. 973-975. by Kenneth Offit posted to breast clinic comments genetics review risk_factor gwas by misonneh on 2009-07-15 04:10:40 as along with 1 person and 2 groups Zephyrus MGEL Reading Breast Cancer Reading Club
	Is Race Really a Negative Prognostic Factor for Cancer? [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 14. (15 July 2009), pp. 970-971. by Otis W. Brawley posted to comments environment epidemiology mortality prognosis race survival by misonneh on 2009-07-15 03:32:15 as along with 2 people and 2 groups songpku Zephyrus MGEL Reading Roswell Cancer Crosstalk
	Two Studies Shed Light on Racial Disparities in Cancer Survival [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 14. (15 July 2009), 969-b. posted to breast comments epidemiology hr race risk_factor survival by misonneh on 2009-07-15 02:49:54 as
	Metformin in Breast Cancer: Time for Action [My Copy] J Clin Oncol, Vol. 27, No. 20. (10 July 2009), pp. 3271-3273. by Pamela J. Goodwin, Jennifer A. Ligibel, Vuk Stambolic posted to breast comments metformin response survival time_to_event by misonneh on 2009-07-13 10:11:20 as
	Invited Commentary: Intrauterine Epidemiology [My Copy] Am. J. Epidemiol., Vol. 170, No. 2. (15 July 2009), pp. 159-161. by Thomas F. Mcelrath, Jonathan L. Hecht posted to comments epidemiology intrauterine by misonneh on 2009-07-13 09:57:46 as
	Genomewide association studies and human disease. [My Copy] The New England journal of medicine, Vol. 360, No. 17. (23 April 2009), pp. 1759-1768. by J. Hardy, A. Singleton posted to comments review gwas by misonneh on 2009-06-29 09:58:43 as along with 10 people and 2 groups PabloMarin daforerog guhjy najwvandijk psique Zephyrus brianb ilyashl farhat jbhiatt MGEL Reading Roswell Cancer Crosstalk
	Are We Hitting the Right Combination for Hormonally Sensitive Breast Cancer? [My Copy] J Clin Oncol, Vol. 27, No. 16. (1 June 2009), pp. 2580-2582. by Debu Tripathy posted to breast comments hormone moa pharmacogenetics review tamoxifen by misonneh on 2009-05-29 06:45:04 as
	Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing? [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 7, No. 2. (February 2009), pp. 203-213. by M. J. Higgins, J. M. Rae, D. A. Flockhart, D. F. Hayes, V. Stearns posted to comments cyp2d6 pharmacogenetics tamoxifen by misonneh on 2009-04-14 06:20:53 as along with 1 person dbs
	Nutritional Prevention of Cancer: New Directions for an Increasingly Complex Challenge [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 6. (18 March 2009), pp. 363-365. by Alan R. Kristal, Scott M. Lippman posted to cancer comments intervention nutrition prevention review by misonneh on 2009-03-18 01:03:07 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
	Why Are a High Overdiagnosis Probability and a Long Lead Time for Prostate Cancer Screening So Important? [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 6. (18 March 2009), pp. 362-363. by Michael J. Barry, Albert J. Mulley posted to comments diagnosis modeling prostate by misonneh on 2009-03-18 00:43:40 as
	RE: "SHOULD META-ANALYSES OF INTERVENTIONS INCLUDE OBSERVATIONAL STUDIES IN ADDITION TO RANDOMIZED CONTROLLED TRIALS? A CRITICAL EXAMINATION OF UNDERLYING PRINCIPLES" [My Copy] Am. J. Epidemiol., Vol. 169, No. 6. (15 March 2009), 783. by Carlos Pereira, Euclides Castilho posted to comments meta_analysis observation randomized_controlled_trial by misonneh on 2009-03-02 01:37:22 as
	Estimating the Impact of the Discontinuation of Medical Interventions on Health Outcomes [My Copy] Am. J. Epidemiol., Vol. 169, No. 6. (15 March 2009), pp. 653-656. by Noel S. Weiss posted to bias clinic comments ddi intervention randomized_controlled_trial by misonneh on 2009-03-02 01:22:24 as
	Getting Up Close and Personal with Your Genome [My Copy] Cell, Vol. 133, No. 5. (30 May 2008), pp. 753-756. by Laura Bonetta posted to comments epigenetics genetics perspective by misonneh on 2009-02-23 05:30:17 as along with 2 people neils balicea
	Epigenomics: Detailed analysis [My Copy] Nature, Vol. 454, No. 7205. (06 August 2008), pp. 795-798. by Laura Bonetta posted to comments epigenetics technology by misonneh on 2009-02-23 05:27:07 as along with 4 people and 1 group Zephyrus frohike reyez jkeilty Roswell Cancer Crosstalk
	Pharmacogenetics--tailoring treatment for the outliers. [My Copy] The New England journal of medicine, Vol. 360, No. 8. (19 February 2009), pp. 811-813. by Janet Woodcock, Lawrence J. Lesko posted to warfarin pharmacogenetics comments by misonneh on 2009-02-20 01:47:18 as
	Surrogate and Mediating Endpoints: Current Status and Future Directions [My Copy] Journal of the National Cancer Instistute, Vol. 101, No. 4. (18 February 2009), pp. 216-217. by Ross L. Prentice posted to clinic comments endpoint survival therapy by misonneh on 2009-02-18 07:29:49 as along with 1 person guhjy
	Mostly, your results matter to others [My Copy] Nat Genet, Vol. 41, No. 2. (February 2009), pp. 135-135. posted to comments guideline microarray by misonneh on 2009-01-29 01:49:58 as along with 2 people Zephyrus paszkows
	CYP2D6 phenotype prediction from genotype: which system is the best? [My Copy] Clinical pharmacology and therapeutics, Vol. 83, No. 2. (February 2008), pp. 225-227. by J. Kirchheiner posted to comments cyp2d6 phenotype by misonneh on 2009-01-23 08:30:24 as
	Improving Women's Health Through Modernization of Our Bioinformatics Infrastructure [My Copy] Clin Pharmacol Ther, Vol. 83, No. 1. (7 November 2007), pp. 192-195. by A. Oliva, E. Pinnow, R. Levin, K. Uhl posted to comments public data_mining by misonneh on 2009-01-23 06:44:05 as
	Bone-marrow-derived cells and cancer--an opportunity for improved therapy. [My Copy] Nature Clinical Practice Oncology, Vol. 4, No. 1. (January 2007), pp. 2-3. by J. Houghton posted to comments hematology therapy by misonneh on 2009-01-19 07:55:31 as
	Cytotoxic-free treatment designs: time to resistance [My Copy] Nature Clinical Practice Oncology, Vol. 4, No. 1. (January 2007), pp. 1-1. by Justin Stebbing, Tim Crook posted to comments pharmacogenetics survival by misonneh on 2009-01-19 07:53:41 as along with 1 person xtizon
	Decanalization and the origin of complex disease [My Copy] Nature Reviews Genetics, Vol. 10, No. 2. (February 2009), pp. 134-140. by Greg Gibson posted to comments genetics review gwas by misonneh on 2009-01-19 07:22:43 as along with 7 people and 1 group psique guhjy Zephyrus shikin wimufi lp2 pkonings Roswell Cancer Crosstalk
	Invited commentary: efficient testing of gene-environment interaction. [My Copy] American journal of epidemiology, Vol. 169, No. 2. (15 January 2009), pp. 231-233. by N. Chatterjee, S. Wacholder posted to comments gxe tutorial gwas by misonneh on 2009-01-14 00:14:37 as along with 2 people and 1 group guhjy Zephyrus Roswell Cancer Crosstalk
	Invited Commentary: From Genome-Wide Association Studies to Gene-Environment-Wide Interaction Studies--Challenges and Opportunities [My Copy] Am. J. Epidemiol., Vol. 169, No. 2. (15 January 2009), pp. 227-230. by Muin J. Khoury, Sholom Wacholder posted to comments gxe tutorial gwas by misonneh on 2009-01-14 00:13:45 as along with 3 people and 1 group guhjy Zephyrus wimufi Roswell Cancer Crosstalk
	Cohort studies and the genetics of complex disease [My Copy] Nature Genetics, Vol. 41, No. 1., pp. 5-6. by Teri A. Manolio posted to cohort comments obesity gwas by misonneh on 2008-12-31 07:48:02 as along with 3 people and 1 group guhjy pkonings Zephyrus Roswell Cancer Crosstalk
	Oncogenesis: It's all about translation [My Copy] Nature Reviews Cancer, Vol. 9, No. 1. (January 2009), pp. 4-5. by Nicola Mccarthy posted to comments instability myc by misonneh on 2008-12-24 07:12:07 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
	Gene Testing to Predict Tamoxifen-Induced Hot Flashes: New Biological Insights [My Copy] J Clin Oncol, Vol. 26, No. 36. (20 December 2008), pp. 5841-5842. by Carolyn J. Crandall posted to adr comments genetics tamoxifen by misonneh on 2008-12-22 03:50:03 as
	A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients? [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 9. (7 May 2008), pp. 610-613. by D. F. Hayes, V. Stearns, J. Rae, D. Flockhart, posted to breast comments cyp2d6 modeling resistance tamoxifen by misonneh on 2008-11-19 05:18:07 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/comments

Result page: 1 2 Next

review	305
breast	260
genetics	162
epigenetics	161
methylation	153
pharmacogenetics	126
statistics	87
gene_specific_methylation	66
comments	65
gwas	63
biomarker	62
prognosis	60
association	53
tamoxifen	53
chemotherapy	47
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
guideline	35
resistance	35
survival	35
meta_analysis	34
global	33
prediction	33
response	32
epidemiology	31
epistasis	30
adr	29
dynamic	28
korean	28
technology	27
diagnosis	26
haplotype	26
prostate	26
time_to_event	25
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
database	19
prevention	19
progression	18
lung	17
perspective	17
risk_factor	17
line1	16
pooling	16
therapy	16
immunity	14
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
phenotype	13
tool	13
5mdc	12
age	12
randomized_controlled_trial	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
hormone	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
her2	7
hla	7
kim_	7
mdr1	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
epilepsy	6
histone	6
hyper_hypo	6
maternal	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
methodology	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
public	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
bayesian	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
egfr_pathway	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovarian	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
risk_assessment	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
anthracycline	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
ki67	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's comments [65 articles] Export

misonneh's tags